ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ODX Omega Diagnostics Group Plc

2.20
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Omega Diagnostics Group Plc LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.20 2.00 2.40 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Omega Diagnostics Share Discussion Threads

Showing 3176 to 3198 of 37200 messages
Chat Pages: Latest  132  131  130  129  128  127  126  125  124  123  122  121  Older
DateSubjectAuthorDiscuss
22/5/2019
14:28
lol, Upomega. At least with the money sorted now, I reckon that this will move up in the coming weeks. You will be OK with your investment.
likitorma
22/5/2019
10:49
Likitorma.. Dont worry i am used to being left out of things. That,s why i,m always found in the kitchen at parties. Joking aside they probably looked to institutional investors for investment
capital. Hopefully this works out cheaper than extending the bank over draft .Inmo this is a good move to cover expenses until sales of CD4 start ( Hopefully ) and food intolerance goes on sale in China.

upomega
22/5/2019
10:14
If a sale of allergy side was imminent then perhaps no raise would have been needed. It's an interesting time but has risk been reduced?

GLA.

p1nkfish
22/5/2019
09:19
How much time does 635K with an overdraft buy them ?

That is the question

buywell2
22/5/2019
09:08
Sneller has become trapped imho. No alternative but to cough up. Harwood are a decent value shop so they must see something here but its pocket change to them.
p1nkfish
22/5/2019
09:06
It's a shame it has come to this. The monies raised being for a final small push and not some grand ambition. Its limping along and what alternative but to break up?
p1nkfish
22/5/2019
08:35
Although I am pretty miffed that this fund-raising is mutually exclusive to a few significant investors , it surely has to be a positive signal to the market ?

Here's why -

1) Sneller and Oryx are taking 76% of the entire issue , meaning their shareholdings go from 20% to 21.3% and 11.1% to 11.95% respectively .

2) There have been rumours of a fund-raising since the solid trading update in mid-April when the shares were 13p , and the RSI last night was below 20 .

3) The announcement reads as though everything is for sale except CD4 ; note there is no mention of food intolerance or allergies , and they have reiterated their year old remark of releasing short-term shareholder value .

4) My guess is that directors are not allowed to subscribe for this issue under LSE close season rules ?

bomber13
22/5/2019
08:19
I await results to see how much of the Bank Overdraft Facility ODX have used. I would expect to see Director buying after the Closed period has ended as there seems to be no Director buying in the Placing which is disappointing, at these low levels..
barrywhit
22/5/2019
08:17
I take Sneller as protecting his capital as without this raise there are problems.

Would have been happier to see Harwood > Sneller as that is more of a value and greed shop imho.

It suggests pressure will be on to sell off parts or all imho. A return for the investors.

p1nkfish
22/5/2019
07:19
Good to see the 2 large holders still confident in ODX..small dilution...now let’s see some progress...
barrywhit
22/5/2019
07:15
Now that the raise is sorted, this can motor on. Shame shareholders like Upomega has not been given the opportunity to participate, despite his close to 2% holdings. Note no directors buying in the placing.
likitorma
22/5/2019
07:10
There you have it, what a shambles, more dilution:
hyperboreus
21/5/2019
23:42
Directors happy to take their 6 digits package while shareholders suffer. Need to get the major shareholders to do something.
likitorma
21/5/2019
07:19
Hope this helps Arthur:
hyperboreus
20/5/2019
23:23
The world functions in weird ways, Upo.
likitorma
20/5/2019
23:19
Let us hope its a partial sale to release some cash likitorma. Otherwise I cant see how the majority of investors together with the bod would benefit by a entire sale of the company.
upomega
20/5/2019
23:05
Upomega, disagree since earliest they have released finals is towards end of June. If I recall correctly, new regs allow 30days for closed period prior to results. These guys have been in closed period for much longer. Mark my words, a sale is coming.
likitorma
20/5/2019
22:46
Probably just down to final results being published as per previous years. Also any non corrupt listed company would be carrying out the same procedure.More so than ever these days inmo
upomega
20/5/2019
21:56
I think there is a sale coming soon; hence, why the directors' are in closed period for such an extended period of time. The larger shareholders have also become insiders to get a feel for consensus; hence why they are not buying. Mark my words.
likitorma
20/5/2019
21:12
As far as I can see it has always been updated.I cant see any news that hasn't been on there for a while.I.e trade fares
upomega
20/5/2019
20:55
They could do with updating the investors section and putting pdf's of the annual reports on there as well.
arthur_lame_stocks
20/5/2019
20:49
Crikey the News & Events section has been updated for the first time in over 12 months, clearly they are taking notice of my posts! 😂
hyperboreus
20/5/2019
19:37
Hopefully we should see some positive news on the launch of advanced cd4 and maybe progress in China re food intolerance. As a positive the company is still recruiting.
upomega
Chat Pages: Latest  132  131  130  129  128  127  126  125  124  123  122  121  Older

Your Recent History

Delayed Upgrade Clock